Korean Drug (Korea) Price Prediction
| 014570 Stock | KRW 4,490 70.00 1.54% |
Oversold Vs Overbought
27
Oversold | Overbought |
Using Korean Drug hype-based prediction, you can estimate the value of Korean Drug Co from the perspective of Korean Drug response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Korean Drug to buy its stock at a price that has no basis in reality. In that case, they are not buying Korean because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Korean Drug after-hype prediction price | KRW 4490.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Korean |
Korean Drug After-Hype Price Prediction Density Analysis
As far as predicting the price of Korean Drug at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Korean Drug or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Korean Drug, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Korean Drug Estimiated After-Hype Price Volatility
In the context of predicting Korean Drug's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Korean Drug's historical news coverage. Korean Drug's after-hype downside and upside margins for the prediction period are 4,489 and 4,491, respectively. We have considered Korean Drug's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Korean Drug is very steady at this time. Analysis and calculation of next after-hype price of Korean Drug is based on 3 months time horizon.
Korean Drug Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Korean Drug is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Korean Drug backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Korean Drug, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.22 | 1.35 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4,490 | 4,490 | 0.00 |
|
Korean Drug Hype Timeline
Korean Drug is presently traded for 4,490on KOSDAQ of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Korean is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.22%. %. The volatility of related hype on Korean Drug is about 0.0%, with the expected price after the next announcement by competition of 4,490. About 50.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Korean Drug had 10:1 split on the 17th of April 2006. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Korean Drug Basic Forecasting Models to cross-verify your projections.Korean Drug Related Hype Analysis
Having access to credible news sources related to Korean Drug's direct competition is more important than ever and may enhance your ability to predict Korean Drug's future price movements. Getting to know how Korean Drug's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Korean Drug may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 046120 | Orbitech Co | 0.00 | 0 per month | 0.00 | (0.08) | 4.47 | (3.89) | 14.11 | |
| 097230 | HJ ShipBuilding Construction | 0.00 | 0 per month | 2.34 | 0.14 | 9.00 | (5.19) | 27.63 | |
| 171120 | Lion Chemtech Co | 0.00 | 0 per month | 1.98 | 0.04 | 4.30 | (3.79) | 16.45 | |
| 052900 | KMH Hitech Co | 0.00 | 0 per month | 0.00 | (0.26) | 2.50 | (3.56) | 7.03 | |
| 403490 | WooDeumGee Farm Co, | 0.00 | 0 per month | 0.00 | (0.17) | 2.02 | (2.50) | 15.97 | |
| 034300 | Shinsegae Engineering Construction | 0.00 | 0 per month | 0.00 | 0.19 | 3.99 | (1.31) | 13.75 | |
| 125210 | Amogreentech Co | 0.00 | 0 per month | 0.00 | (0.21) | 5.64 | (5.16) | 19.13 | |
| 012205 | Keyang Electric Machinery | 0.00 | 0 per month | 0.00 | (0.18) | 2.84 | (3.38) | 8.48 |
Korean Drug Additional Predictive Modules
Most predictive techniques to examine Korean price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Korean using various technical indicators. When you analyze Korean charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Korean Drug Predictive Indicators
The successful prediction of Korean Drug stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Korean Drug Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Korean Drug based on analysis of Korean Drug hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Korean Drug's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Korean Drug's related companies.
Story Coverage note for Korean Drug
The number of cover stories for Korean Drug depends on current market conditions and Korean Drug's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Korean Drug is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Korean Drug's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Korean Drug Short Properties
Korean Drug's future price predictability will typically decrease when Korean Drug's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Korean Drug Co often depends not only on the future outlook of the potential Korean Drug's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Korean Drug's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.8 M | |
| Cash And Short Term Investments | 27.9 B |
Complementary Tools for Korean Stock analysis
When running Korean Drug's price analysis, check to measure Korean Drug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Korean Drug is operating at the current time. Most of Korean Drug's value examination focuses on studying past and present price action to predict the probability of Korean Drug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Korean Drug's price. Additionally, you may evaluate how the addition of Korean Drug to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |